A therapeutic approach to low-grade serous ovarian carcinoma
Low-grade serous ovarian cancer (LGSOC) has less aggressive behavior and a better clinical outcome than high-grade serous ovarian cancer (HGSOC). Considering that this malignancy is relatively chemoresistant, surgery is the keystone of treatment, with a strong recommendation for maximal cytoreductio...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
University Hospital for Tumors
2020-01-01
|
Series: | Libri Oncologici |
Subjects: | |
Online Access: | https://hrcak.srce.hr/file/364268 |